MORGAN STANLEY PLC/CALL/AMGEN/480/0.1/20.12.24 | Delayed Börse Stuttgart 02:42:56 10/06/2024 pm IST | ||
| 0.149 EUR | -16.29% |
|
| Current month | -6.32% | ||
| 1 month | +7.23% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 10/24/10 | 0.149 | -16.29% |
| 07/24/07 | 0.178 | +0.56% |
| 06/24/06 | 0.177 | -9.23% |
| 05/24/05 | 0.195 | +1.56% |
| 04/24/04 | 0.192 | -2.54% |
Delayed Quote Börse Stuttgart
Last update June 10, 2024 at 02:42 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MB0FW5 |
| ISIN | DE000MB0FW54 |
| Date issued | 10/11/2022 |
| Strike | 480 $ |
| Maturity | 20/12/2024 (194 Days) |
| Parity | 10 : 1 |
| Emission price | 0.43 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.97 € |
|---|---|
| Lowest since issue | 0.087 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Warrants
- Warrant
